| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 01/12/2011 | CN1816548B Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| 01/12/2011 | CN101945877A Pyrrolopyrazine kinase inhibitors |
| 01/12/2011 | CN101945876A Nitrogen-containing bicyclic compounds active on chronic pain conditions |
| 01/12/2011 | CN101945875A Azaindolizines and methods of use |
| 01/12/2011 | CN101945874A 3-substituted-4-0x0-3, 4-dihydro-imidazo- [5, 1-d] [1,2,3,5] -tetrazine-8-carboxylic acid amides as anticancer agents |
| 01/12/2011 | CN101945873A Stable crystal of beta-lactam compound |
| 01/12/2011 | CN101945870A 5-anilinoimidazopyridines and methods of use |
| 01/12/2011 | CN101945868A Gamma secretase modulators |
| 01/12/2011 | CN101945867A Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors |
| 01/12/2011 | CN101941975A Method for preparing heme from animal blood corpuscle powder serving as raw material |
| 01/12/2011 | CN101357921B New dipeptidase-IV inhibitor compound |
| 01/11/2011 | US7868205 N-[2-amino-5-(2-thienyl)phenyl]-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide; antiproliferative, antiprotozoal agent; lymphoma, lung cancer, colon cancer, prostrate cancer, stomach cancer, breast cancer, leukemia |
| 01/11/2011 | US7868204 Inhibitors of histone deacetylase |
| 01/11/2011 | US7868181 Compounds |
| 01/11/2011 | US7868013 Cycloalkyl substituted pyrimidinediamine compounds and their uses |
| 01/11/2011 | US7868001 such as 2-(3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)imidazo[1,2-b]pyridazine, used for decreasing the levels of tumor necrosis factors or interleukines; treatment of inflammation, autoimmune diseases, diabetes, atherosclerosis and cancer |
| 01/11/2011 | US7868000 Aspartyl protease inhibitors |
| 01/11/2011 | CA2536384C Cyclic derivatives as modulators of chemokine receptor activity |
| 01/11/2011 | CA2518740C Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 01/11/2011 | CA2451678C Azaindoles |
| 01/11/2011 | CA2430124C Lactam compounds and pharmaceutical use thereof |
| 01/11/2011 | CA2422054C Bicyclic heteroaromatic compounds |
| 01/11/2011 | CA2420592C Fused pyrrolocarbazoles against inflammation |
| 01/11/2011 | CA2407593C Fused heteroaryl derivatives |
| 01/11/2011 | CA2385592C Benzamides and related inhibitors of factor xa |
| 01/06/2011 | WO2011003065A2 Pyrazolopyrimidine jak inhibitor compounds and methods |
| 01/06/2011 | WO2011002887A1 FUSED TRICYCLIC COMPOUNDS AS NOVEL mTOR INHIBITORS |
| 01/06/2011 | WO2011002808A1 Hcv protease inhibitors and uses thereof |
| 01/06/2011 | WO2011002807A1 Hcv protease inhibitors and uses thereof |
| 01/06/2011 | WO2011002409A1 5h-pyrrolo[3,4-£>]pyrazin-7-amine derivatives inhibitors of beta-secretase |
| 01/06/2011 | WO2011002076A1 Method for producing lactam compound and production intermediate thereof |
| 01/06/2011 | WO2011002075A1 Method for producing lactam compound and production intermediate thereof |
| 01/06/2011 | WO2011002067A1 Heterocyclic compound and use thereof |
| 01/06/2011 | WO2011001113A2 Novel 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof |
| 01/06/2011 | WO2011001112A1 Novel 2,3-dihydro-1h-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof, and pharmaceutical use thereof |
| 01/06/2011 | WO2011000455A1 Materials for organic electroluminescence devices |
| 01/06/2011 | WO2010129656A8 Method of oligonucleotide labeling using cycloaddition reaction |
| 01/06/2011 | WO2010104843A3 Substituted heterocycles and their use as allosteric modulators of nicotinic and gabaa receptors |
| 01/06/2011 | US20110004951 Methods and compositions for identifying compounds that inhibit hiv-1 subunit-specific reverse transcriptase |
| 01/06/2011 | US20110004004 Pyrrolopyrrole derivatives, their manufacture and use |
| 01/06/2011 | US20110003849 Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment |
| 01/06/2011 | US20110003824 Caspase Inhibitors and Uses Thereof |
| 01/06/2011 | US20110003820 Pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 01/06/2011 | US20110003810 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors |
| 01/06/2011 | US20110003807 Thiazole derivatives |
| 01/06/2011 | US20110003806 Heteroaryls and uses thereof |
| 01/06/2011 | US20110003805 Concomitant drug |
| 01/06/2011 | US20110003802 Bridged N-Cyclic Sulfonamido Inhibitors of Gamma Secretase |
| 01/06/2011 | US20110003793 AZINONE-SUBSTITUTED AZEPINO[b]INDOLE AND PYRIDO-PYRROLO-AZEPINE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USE THEREOF |
| 01/06/2011 | US20110003739 Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof |
| 01/06/2011 | US20110003738 Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof |
| 01/06/2011 | US20110003737 Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof |
| 01/06/2011 | US20110003396 Explosives detection markers |
| 01/06/2011 | US20110003362 Conjugates of biological substances |
| 01/06/2011 | US20110002985 Abuse resistant drugs, method of use and method of making |
| 01/06/2011 | US20110001093 Fullerene derivative |
| 01/06/2011 | CA2767097A1 Pyrazolopyrimidine jak inhibitor compounds and methods |
| 01/06/2011 | CA2767051A1 Novel 2,3-dihydro-1h-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof, and pharmaceutical use thereof |
| 01/06/2011 | CA2766909A1 Novel 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof |
| 01/05/2011 | EP2270114A1 Photobase generator |
| 01/05/2011 | EP2270107A1 Compounds for Dual Photodiagnosis and Therapy |
| 01/05/2011 | EP2270016A1 Preparation of metal mesoporphyrin halide compounds |
| 01/05/2011 | EP2270015A1 Rna-selective hybridization reagent and utilization of the same |
| 01/05/2011 | EP2270014A1 Azepine inhibitors of janus kinases |
| 01/05/2011 | EP2270013A1 Crystalline form of pemetrexed diacid and process for the preparation thereof |
| 01/05/2011 | EP2270012A1 Crystalline form of pemetrexed diacid and process for the preparation thereof |
| 01/05/2011 | EP2270011A1 Condensed imidazolo derivatives for the inhibition of aromatase |
| 01/05/2011 | EP2270010A1 11-hydroxy-5h-pyrrolo[2,1-c][1,4]benzodiazepin-5-one derivatives as key intermediates for the preparation of c2 substituted pyrrolobenzodiazepins |
| 01/05/2011 | EP2270009A1 Process for the preparation of sitagliptin |
| 01/05/2011 | EP2268642A1 1' -substituted carba-nucleoside analogs for antiviral treatment |
| 01/05/2011 | EP2268636A1 Gamma secretase modulators |
| 01/05/2011 | EP2121696B1 Compounds for the treatment of hepatitis c |
| 01/05/2011 | EP2094706B1 Substituted 2,5-dfflydro-3h-pyrazolo[4,3-c]pyridazin-3-one derivatives, preparation thereof and use of same as cannabinoid cb1 receptor ligands |
| 01/05/2011 | EP2054416B1 Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 01/05/2011 | EP1912999B1 Macrocyclic inhibitors of hepatitis c virus |
| 01/05/2011 | EP1881977B1 Histone deacetylase inhibitors |
| 01/05/2011 | EP1720882B1 Pyrazolopyrimidine-derivatives as cyclin dependent kinase inhibitors |
| 01/05/2011 | EP1433480B1 Medicine containing pyrimidine derivative |
| 01/05/2011 | CN101939324A Pyrrolopyrazine kinase inhibitors |
| 01/05/2011 | CN101939323A Pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 01/05/2011 | CN101939322A Sildenafil n-oxide as prodrug |
| 01/05/2011 | CN101939315A Gamma secretase modulators |
| 01/05/2011 | CN101939302A Mesoionic pesticides |
| 01/05/2011 | CN101939054A Organic compounds |
| 01/05/2011 | CN101935323A Purification method of deuterohemin |
| 01/05/2011 | CN101935322A Diazabicyclic central nervous system active agents |
| 01/05/2011 | CN101933926A Indolylmaleimde derivatives as PKC inhibitors |
| 01/05/2011 | CN101089000B Spiro piperazine quaternary ammonium salt compound and its preparation method and application |
| 01/04/2011 | US7863445 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 01/04/2011 | US7863444 Antiproliferative agents; anticancer agents; antiarthritic agents; antiinflamamtory agents |
| 01/04/2011 | US7863289 Compounds and methods for kinase modulation, and indications therefor |
| 01/04/2011 | US7863281 4-[(3-chloro-4-fluoro-phenyl)amino]-6-{[4-((1S,4S)-2-oxa-5-aza-bicyclo[2.2.1]hept-5-yl)-1-oxo-2-buten-1-yl]amino}-7-cyclopropylmethoxy-quinazoline; inhibitor of signal transduction mediated by tyrosine kinases; antitumor agent; benign prostatic hyperplasia, lungs and respiratory tract disease; bile duct |
| 01/04/2011 | US7863081 organic semiconductor layer for a field effect transistor comprising bicycloporphyrin copper complex compound; high field effect mobility |
| 01/04/2011 | CA2468517C Thioether substituted imidazoquinolines |
| 01/04/2011 | CA2454703C Novel thiophene carboxamide derivatives |
| 01/04/2011 | CA2377671C High density non-volatile memory device |
| 12/30/2010 | US20100331541 Process for the preparation of sitagliptin |
| 12/30/2010 | US20100331382 Processes of making and using pharmaceutical formulations of antineoplastic agents |
| 12/30/2010 | US20100331350 Inhibitors of bruton's tyrosine kinase |
| 12/30/2010 | US20100331347 (en) 3-sulfonyl-pyrazolo[1,5-a] pyrimidines / antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof |